1-9 of 9
Dagmar Bund
Close
Sort by
Journal Articles

Long-Term Results of Donor Lymphocyte Transfusions for the Treatment of Relapse After Allogeneic Transplantation for Chronic Myelogenous Leukemia - Is There a Role for Immunotherapy in CML?.

Hans-Jochem Kolb, Dagmar Bund, PhD, Helga Schmetzer, PhD, Prof, Christoph Schmid, MD, PhD, Raymund Buhmann, MD, Johanna Tischer, MD, Georg Ledderose, MD
Journal: Blood
Blood (2009) 114 (22): 2258.
https://doi.org/10.1182/blood.V114.22.2258.2258
Published: 2009
Journal Articles

IFN-Alpha and gm-CSF Can Reverse Immunomodulatory Effects of Imatinib

Dagmar Bund, Raymund Buhmann, Hans Jochem Kolb, MD
Journal: Blood
Blood (2008) 112 (11): 2903.
https://doi.org/10.1182/blood.V112.11.2903.2903
Published: 2008
Journal Articles

UTY-Coded Minor Histocompatibility Antigens as Targets for a Graft- Versus-Host Reaction against Hematopoietic Cells in the Dog.

Dagmar Bund, Raymund Buhmann, Julia Zorn, Helga Schmetzer, Jr., Hans- Jochem Kolb
Journal: Blood
Blood (2008) 112 (11): 2339.
https://doi.org/10.1182/blood.V112.11.2339.2339
Published: 2008
Journal Articles

Y-Chromosome Genes Strongly Expressed in Acute Myeloid Leukaemia.

Antonio Gallo, PhD, Dagmar Bund, PhD, Rebecca Mindnich, PhD, Raymund Buhmann, MD, Helga Schmetzer, PhD, Jerzy Adamski, PhD, Hans-Jochem Kolb, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4901.
https://doi.org/10.1182/blood.V110.11.4901.4901
Published: 2007
Journal Articles

Immune Effects of Imatinib in Chronic Myelogenous Leukemia In Vitro.

Dagmar Bund, PhD, Raymund Buhmann, MD, Hans-Jochem Kolb, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2956.
https://doi.org/10.1182/blood.V110.11.2956.2956
Published: 2007
Journal Articles

Immunomodulatory Effects of STI571 in Chronic Myeloid Leukaemia.

Dagmar Bund, PhD, Ting Yang, MD, Raymund Buhmann, MD, Hans-Jochem Kolb
Journal: Blood
Blood (2006) 108 (11): 2198.
https://doi.org/10.1182/blood.V108.11.2198.2198
Published: 2006
Journal Articles

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Brief Report
Christine Mayr, David M. Kofler, Hildegard Büning, Dagmar Bund, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 106 (9): 3223–3226.
https://doi.org/10.1182/blood-2005-04-1742
Published: 2005
Journal Articles

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Christine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M. Kofler, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 105 (4): 1566–1573.
https://doi.org/10.1182/blood-2004-04-1233
Published: 2005
Journal Articles

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Christine Mayr, MD, Dagmar Bund, Martin Schlee, PhD, Andreas Moosmann, PhD, Michael Hallek, MD, Clemens Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 175.
https://doi.org/10.1182/blood.V104.11.175.175
Published: 2004